Class information for:
Level 1: CBL//CBL B//C CBL

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
14390 772 48.9 95%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
269 3       CELL BIOLOGY//CAVEOLIN 1//CAVEOLAE 44007
536 2             X LINKED AGAMMAGLOBULINEMIA//BTK//SH2 DOMAIN 14793
14390 1                   CBL//CBL B//C CBL 772

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CBL authKW 1157900 11% 35% 84
2 CBL B authKW 1001963 5% 67% 38
3 C CBL authKW 766355 6% 41% 47
4 CIN85 authKW 545535 3% 69% 20
5 SLAP 2 authKW 203409 1% 86% 6
6 CBL FAMILY authKW 158209 1% 100% 4
7 NEIL BOGART MEM S address 158205 1% 67% 6
8 CBL PROTEINS authKW 141255 1% 71% 5
9 RNF13 authKW 141255 1% 71% 5
10 TULA authKW 141255 1% 71% 5

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Cell Biology 3501 35% 0% 270
2 Biochemistry & Molecular Biology 2352 47% 0% 359
3 Immunology 1352 21% 0% 164
4 Oncology 561 16% 0% 121
5 Hematology 310 7% 0% 53
6 Genetics & Heredity 269 9% 0% 70
7 Biophysics 105 5% 0% 41
8 Medicine, Research & Experimental 62 5% 0% 35
9 Endocrinology & Metabolism 12 3% 0% 22
10 Developmental Biology 12 1% 0% 9

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 NEIL BOGART MEM S 158205 1% 67% 6
2 BACTERIAL INFECT IMMUN 105470 1% 67% 4
3 MEDLYMPHOCYTE BIOL SECT 82395 1% 42% 5
4 HEMATOL ONCOL MS 57 79104 0% 100% 2
5 BIOL PATHOL OSTEOBLASTE 39552 0% 100% 1
6 BIOL STRUCT BIOPHYSPROTEOM GENOPOLE TOULOUS 39552 0% 100% 1
7 BIOMED BIOTECNOL CANTABRIA BIOL MOL 39552 0% 100% 1
8 CANC BIOL IMMUNOL GRP 39552 0% 100% 1
9 CHINESE MED SCI BASIC MED SCI 39552 0% 100% 1
10 CHINESE MED SCI BASIC MEDPEKING UNION M 39552 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ONCOGENE 3637 5% 0% 41
2 JOURNAL OF BIOLOGICAL CHEMISTRY 2843 14% 0% 106
3 JOURNAL OF IMMUNOLOGY 1506 6% 0% 46
4 NATURE IMMUNOLOGY 1437 1% 0% 9
5 CRITICAL REVIEWS IN ONCOGENESIS 1204 0% 2% 2
6 IMMUNITY 1137 1% 0% 10
7 INTERNATIONAL REVIEW OF AFRICAN AMERICAN ART 704 0% 2% 1
8 JOURNAL OF EXPERIMENTAL MEDICINE 702 2% 0% 15
9 NEW STATESMAN & SOCIETY 681 0% 1% 2
10 CELLULAR SIGNALLING 567 1% 0% 8

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CBL 1157900 11% 35% 84 Search CBL Search CBL
2 CBL B 1001963 5% 67% 38 Search CBL+B Search CBL+B
3 C CBL 766355 6% 41% 47 Search C+CBL Search C+CBL
4 CIN85 545535 3% 69% 20 Search CIN85 Search CIN85
5 SLAP 2 203409 1% 86% 6 Search SLAP+2 Search SLAP+2
6 CBL FAMILY 158209 1% 100% 4 Search CBL+FAMILY Search CBL+FAMILY
7 CBL PROTEINS 141255 1% 71% 5 Search CBL+PROTEINS Search CBL+PROTEINS
8 RNF13 141255 1% 71% 5 Search RNF13 Search RNF13
9 TULA 141255 1% 71% 5 Search TULA Search TULA
10 C CB1 88991 0% 75% 3 Search C+CB1 Search C+CB1

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 SWAMINATHAN, G , TSYGANKOV, AY , (2006) THE CBL FAMILY PROTEINS: RING LEADERS IN REGULATION OF CELL SIGNALING.JOURNAL OF CELLULAR PHYSIOLOGY. VOL. 209. ISSUE 1. P. 21-43 167 54% 164
2 MOHAPATRA, B , AHMAD, G , NADEAU, S , ZUTSHI, N , AN, W , SCHEFFE, S , DONG, L , FENG, D , GOETZ, B , ARYA, P , ET AL (2013) PROTEIN TYROSINE KINASE REGULATION BY UBIQUITINATION: CRITICAL ROLES OF CBL-FAMILY UBIQUITIN LIGASES.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. VOL. 1833. ISSUE 1. P. 122 -139 106 51% 39
3 LEE, H , TSYGANKOV, AY , (2013) CBL-FAMILY PROTEINS AS REGULATORS OF CYTOSKELETON-DEPENDENT PHENOMENA.JOURNAL OF CELLULAR PHYSIOLOGY. VOL. 228. ISSUE 12. P. 2285-2293 113 57% 4
4 THIEN, CBF , LANGDON, WY , (2001) CBL: MANY ADAPTATIONS TO REGULATE PROTEIN TYROSINE KINASES.NATURE REVIEWS MOLECULAR CELL BIOLOGY. VOL. 2. ISSUE 4. P. 294 -305 79 75% 418
5 TSYGANKOV, AY , TECKCHANDANI, AM , FESHCHENKO, EA , SWAMINATHAN, G , (2001) BEYOND THE RING: CBL PROTEINS AS MULTIVALENT ADAPTERS.ONCOGENE. VOL. 20. ISSUE 44. P. 6382 -6402 132 53% 95
6 THIEN, CBF , LANGDON, WY , (2005) C-CBL AND CBL-B UBIQUITIN LIGASES: SUBSTRATE DIVERSITY AND THE NEGATIVE REGULATION OF SIGNALLING RESPONSES.BIOCHEMICAL JOURNAL. VOL. 391. ISSUE . P. 153-166 88 63% 127
7 LIU, QJ , ZHOU, H , LANGDON, WY , ZHANG, J , (2014) E3 UBIQUITIN LIGASE CBL-B IN INNATE AND ADAPTIVE IMMUNITY.CELL CYCLE. VOL. 13. ISSUE 12. P. 1875 -1884 74 68% 5
8 LIYASOVA, MS , MA, K , LIPKOWITZ, S , (2015) MOLECULAR PATHWAYS: CBL PROTEINS IN TUMORIGENESIS AND ANTITUMOR IMMUNITY-OPPORTUNITIES FOR CANCER TREATMENT.CLINICAL CANCER RESEARCH. VOL. 21. ISSUE 8. P. 1789 -1794 49 84% 7
9 DIKIC, I , SZYMKIEWICZ, I , SOUBEYRAN, P , (2003) CBL SIGNALING NETWORKS IN THE REGULATION OF CELL FUNCTION.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 60. ISSUE 9. P. 1805-1827 110 52% 61
10 SCHMIDT, MHH , DIKIC, I , (2005) THE CBL INTERACTOME AND ITS FUNCTIONS.NATURE REVIEWS MOLECULAR CELL BIOLOGY. VOL. 6. ISSUE 12. P. 907 -918 70 58% 237

Classes with closest relation at Level 1


Rank Class id link
1 13788 SLP 76//ADAP//SECT LYMPHOCYTE SIGNALING
2 22610 WWP1//WW DOMAIN//CKIP 1
3 13570 NEDD9//CRK//CRKL
4 23744 SPROUTY//SPROUTY2//SPRED
5 6889 ESCRT//TSG101//ALG 2
6 22654 VAV//VAV1//VAV PROTO ONCOGENE
7 18972 SYK//SPLEEN TYROSINE KINASE//FOSTAMATINIB
8 21034 GRB7//GRB14//GRB10
9 12290 SH3 DOMAIN//SH2 DOMAIN//GRB2
10 5087 EGF RECEPTOR//COMPUTER PROGRAM FOR MACINTOSHTMII//DIMERIZATION ARM

Go to start page